352 related articles for article (PubMed ID: 16352273)
1. Adverse reactions of low osmolar non-ionic and ionic contrast media when used together or separately during percutaneous coronary intervention.
Juergens CP; Khaing AM; McIntyre GJ; Leung DY; Lo ST; Fernandes C; Hopkins AP
Heart Lung Circ; 2005 Sep; 14(3):172-7. PubMed ID: 16352273
[TBL] [Abstract][Full Text] [Related]
2. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sodium-meglumine ioxaglate and iopromide in coronary angiography.
Neiss AC; Barth P; Chastin I; Erdmann E
Ann Radiol (Paris); 1989; 32(1):49-53. PubMed ID: 2662884
[TBL] [Abstract][Full Text] [Related]
4. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
5. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
Bertrand ME; Esplugas E; Piessens J; Rasch W
Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
[TBL] [Abstract][Full Text] [Related]
6. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
Le Feuvre C; Batisse A; Collet JP; Batisse JP; Choussat R; Beygui F; Helft G; Montalescot G; Metzger JP
Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
Schräder R; Esch I; Ensslen R; Fach WA; Merle H; Scherer D; Sievert H; Spies HF; Zeplin HE
J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
[TBL] [Abstract][Full Text] [Related]
8. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
Sutton AG; Ashton VJ; Campbell PG; Price DJ; Hall JA; de Belder MA
Catheter Cardiovasc Interv; 2002 Nov; 57(3):346-52. PubMed ID: 12410513
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina.
Qureshi NR; den Heijer P; Crijns HJ
Am J Cardiol; 1997 Sep; 80(6):700-4. PubMed ID: 9315572
[TBL] [Abstract][Full Text] [Related]
10. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
[TBL] [Abstract][Full Text] [Related]
11. Allergic-type adverse reactions to low osmolality contrast media in patients with a history of allergy or asthma.
Simon MR
Invest Radiol; 1995 May; 30(5):285-90. PubMed ID: 7558732
[TBL] [Abstract][Full Text] [Related]
12. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
Liss P; Persson PB; Hansell P; Lagerqvist B
Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
[TBL] [Abstract][Full Text] [Related]
13. [Iopromide 370 in coronaroventriculography, versus ioxaglate 320 mg/ml].
Petitier H
Ann Radiol (Paris); 1989; 32(4 Pt 2):333-5. PubMed ID: 2688529
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST trial.
Chen JY; Liu Y; Zhou YL; Tan N; Zhang B; Chen PY; Chen LB
Int J Cardiovasc Imaging; 2015 Oct; 31(7):1281-91. PubMed ID: 26058857
[TBL] [Abstract][Full Text] [Related]
15. Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angiography and stenting.
Scheller B; Speck U; Schmitt A; Clauss W; Sovak M; Böhm M; Stoll HP
Invest Radiol; 2002 Jan; 37(1):29-34. PubMed ID: 11753151
[TBL] [Abstract][Full Text] [Related]
16. Effects of radiographic contrast media on pulmonary vascular resistance of normoxic and chronically hypoxic pulmonary hypertensive rats.
Emery CJ; Fang L; Laude EA; Morcos SK
Br J Radiol; 2001 Dec; 74(888):1109-17. PubMed ID: 11777768
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions of low osmolality contrast media during cardiac angiography: a prospective randomized multicenter study.
Gertz EW; Wisneski JA; Miller R; Knudtson M; Robb J; Dragatakis L; Browne KF; Vetrovec G; Smith SC
J Am Coll Cardiol; 1992 Apr; 19(5):899-906. PubMed ID: 1552109
[TBL] [Abstract][Full Text] [Related]
18. Risk of thrombosis during coronary angioplasty with low osmolality contrast media.
Esplugas E; Cequier A; Jara F; Mauri J; Soler T; Sala J; Sabate X
Am J Cardiol; 1991 Oct; 68(10):1020-4. PubMed ID: 1927914
[TBL] [Abstract][Full Text] [Related]
19. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
20. [Contrast media in peripheral angiography: does cost reduction mean loss of quality and safety? A reevaluation based on a randomized double-blind comparative study of ioxaglate versus iopromide].
Lammer J; Winkelbauer F; Thurnher S; Wildling R; Farres MT; Woessmer B
Rofo; 1996 May; 164(5):432-6. PubMed ID: 8634406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
